Literature DB >> 7536337

Captopril increases endothelin serum concentrations and preserves intestinal mucosa after mesenteric ischemia-reperfusion injury.

O Büyükgebiz1, A O Aktan, C Yeğen, A S Yalçin, G Haklar, R Yalin, Z S Ercan.   

Abstract

Endothelial cells modulate the tone of the underlying smooth muscle by generating endothelium-derived relaxing and constricting factors. Captopril (CPT), unlike other angiotensin-converting enzyme (ACE) inhibitors, contains a sulfhydryl (-SH) group and can act as a free radical scavenger. Iloprost (ILO) is a synthetic analogue of prostacyclin and mimics the effects of this compound. This study was designed to investigate the effect of ILO and CPT on the mechanism of endothelin (ET) release after mesenteric ischemia-reperfusion (I/R) injury in the rat. Sprague-Dawley rats were divided into five groups: sham-operated, control, ILO (25 micrograms/kg), CPT (10 micrograms/kg), and ILO + CPT. The superior mesenteric artery was occluded for 30 min and then allowed 90 min of reperfusion, except in the sham-operated group, and the corresponding agents were given to the treated groups prior to I/R injury. After I/R injury, portal venous blood was obtained for ET assay, and ileal tissue samples were also obtained for the determination of malondialdehyde (MDA), prostaglandin E2 (PGE2) and leukotriene C4 (LTC4) and for histopathological examination. MDA levels were significantly lower in the CPT, ILO and, ILO + CPT groups than in the control group, indicating the inhibition of lipid peroxidation in all groups. ET levels increased in the control group, and this increase was reversed with ILO. In the CPT group, ET levels were significantly increased, and the addition of ILO did not affect this increase. Significant cytopreservative effect was achieved with ILO and CPT, the latter being more prominent histopathologically. CPT exerts a significant protective effect on the intestinal mucosa after I/R injury. This protection is accomplished by increased ET levels and seems to be unrelated to its inhibitory effect on lipid peroxidation and also unrelated to the arachidonic acid cascade.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7536337     DOI: 10.1007/bf02576396

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  6 in total

Review 1.  Bone marrow lesions and subchondral bone pathology of the knee.

Authors:  Elizaveta Kon; Mario Ronga; Giuseppe Filardo; Jack Farr; Henning Madry; Giuseppe Milano; Luca Andriolo; Nogah Shabshin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-13       Impact factor: 4.342

2.  Role of endothelin in obstructive jaundice.

Authors:  A M Sarac; A O Aktan; H Moini; S Bilsel; E Scapa
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

Review 3.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

4.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

5.  Oxidative stress and ischemia-reperfusion injury in gastrointestinal tract and antioxidant, protective agents.

Authors:  Makoto Sasaki; Takashi Joh
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

6.  Rationale for prostaglandin I2 in bone marrow oedema--from theory to application.

Authors:  Marcus Jäger; Frank Peter Tillmann; Thomas S Thornhill; Marcus Mahmoudi; Dirk Blondin; Gerd Rüdiger Hetzel; Christoph Zilkens; Rüdiger Krauspe
Journal:  Arthritis Res Ther       Date:  2008-10-03       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.